Last reviewed · How we verify
Pharyngitis/tonsillitis — Treatment Landscape & Competitive Intelligence
1 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Test formulation (Treatment A) | test-formulation-treatment-a | Pfizer | Enzyme inhibitor | Specific enzyme | Not yet determined |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- Pfizer · 1 drug in Pharyngitis/tonsillitis
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Pharyngitis/tonsillitis:
- Pharyngitis/tonsillitis treatment updates — RSS
- Pharyngitis/tonsillitis treatment updates — Atom
- Pharyngitis/tonsillitis treatment updates — JSON
Cite this brief
Drug Landscape (2026). Pharyngitis/tonsillitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/pharyngitis-tonsillitis. Accessed 2026-06-10.
Related
- Pharyngitis/tonsillitis full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing